InsiderTrades

Form 4 for NKE Nike, Inc.

Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-13 · accession 0001127602-22-027557 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-15 2022-12-13 NKE Matheson Monique S. EVP: CHRO S - Sale+OE $115.83 -5,000 60.2K -8% -$579.1K
D 2022-12-15 2022-12-13 NKE Matheson Monique S. EVP: CHRO M - OptEx $57.87 +5,000 65.2K +8% +$289.4K
D 2022-12-15 2022-12-13 NKE Matheson Monique S. EVP: CHRO M - OptEx $0.00 -5,000 5,000 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class B Common Stock 2022-12-13 S D 5,000 $115.83 60,213.11 D — — (F1) Exercise and sale was pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
2 Common Class B Common Stock 2022-12-13 M A 5,000 $57.87 65,213.11 D — — (F1) Exercise and sale was pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. (F2) Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.
3 Derivative Non-Qualified Stock Option (Right to Buy) 2022-12-13 M D 5,000 $0.00 5,000 D $57.87 · — to 2026-07-15 5,000 Class B Common Stock (F4) Stock Option granted on 07/15/2016 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.